FDA Inspection 1156019 — Lonza Walkersville, Inc.

Lonza Walkersville, Inc. — FEI 1114298

The FDA completed an inspection of Lonza Walkersville, Inc. on Nov 5, 2021 in Walkersville, MD. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 6 citations were issued during this inspection. Product area: Devices.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Nov 5, 2021
Fiscal Year
2022
Product Type
Devices
Project Area
Compliance: Devices
Location
Walkersville, MD (United States)

Citations

IDCFRDescription
1471321 CFR 820.198(a)Lack of or inadequate complaint procedures
310821 CFR 820.70(e)Contamination control, Lack of or inadequate procedures
311921 CFR 820.75(b)Lack/Inad procedure-Monitoring/Control of Validated Proces
313021 CFR 820.100(a)Lack of or inadequate procedures
328621 CFR 820.90(b)(1)Procedures for product review,disposition lack of/inadequate
54621 CFR 820.75(a)Lack of or inadequate process validation

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.